By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Carbylan Therapeutics (Formerly Known As Carbylan BioSurgery, Inc.) 

3181 Porter Drive

Palo Alto  California  94304  U.S.A.
Phone: 650-855-6777 Fax: 650-855-9119


Medical Device

Start Up

Company News
Carbylan Therapeutics Schedules Second Quarter 2015 Financial Results 7/28/2015 7:56:32 AM
Carbylan Therapeutics Provides Timeline Update For Phase III Clinical Program 7/16/2015 7:27:36 AM
Carbylan Therapeutics Appoints Dr. Prem Ramiya Vice President, Pharmaceutical Development & Supply Chain 7/8/2015 7:23:42 AM
Carbylan Therapeutics To Present At The JMP Securities 2015 Life Sciences Conference 6/18/2015 8:01:08 AM
Carbylan Therapeutics Completes Enrollment Of Phase III Pivotal Trial For Hydros-TA 6/9/2015 7:19:56 AM
Carbylan Therapeutics Announces First Quarter 2015 Financial Results 5/20/2015 8:06:23 AM
Carbylan Therapeutics Announces Pricing Of Initial Public Offering 4/9/2015 5:45:28 AM
David M. Renzi Named New CEO at Carbylan BioSurgery, Inc. 7/16/2013 6:49:44 AM
Carbylan BioSurgery, Inc. Announces Positive Clinical Trial Results for Hydros-TA in Patients With Pain From Knee Osteoarthritis 7/26/2011 6:30:55 AM
Carbylan BioSurgery, Inc. Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued 1/5/2011 7:07:54 AM